UCFA
HZNP

United Capital Financial Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

United Capital Financial Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,169
Closed -$702K – 1099
2022
Q4 		$702K Sell
6,169
-616
-9% -$51.2K ﹤0.01% 693
2022
Q3 		$420K Sell
6,785
-8,766
-56% -$613K ﹤0.01% 799
2022
Q2 		$1.24M Buy
15,551
+10,953
+238% +$1.04M 0.01% 590
2022
Q1 		$484K Sell
4,598
-104
-2% -$10.1K ﹤0.01% 839
2021
Q4 		$507K Buy
4,702
+187
+4% +$20.4K ﹤0.01% 854
2021
Q3 		$495K Sell
4,515
-96
-2% -$9.97K ﹤0.01% 861
2021
Q2 		$432K Sell
4,611
-270
-6% -$24.8K ﹤0.01% 911
2021
Q1 		$449K Sell
4,881
-189
-4% -$15.9K ﹤0.01% 875
2020
Q4 		$371K Buy
5,070
+924
+22% +$68.7K ﹤0.01% 933
2020
Q3 		$322K Buy
4,146
+210
+5% +$14.4K ﹤0.01% 938
2020
Q2 		$219K Buy
+3,936
New +$168K ﹤0.01% 1077
2017
Q3 		– Sell
-37,009
Closed -$439K – 1352
2017
Q2 		$439K Sell
37,009
-97,952
-73% -$1.22M ﹤0.01% 961
2017
Q1 		$2M Buy
134,961
+20,198
+18% +$327K 0.02% 574
2016
Q4 		$1.86M Buy
114,763
+11,689
+11% +$212K 0.02% 582
2016
Q3 		$1.87M Sell
103,074
-1,265
-1% -$24.7K 0.02% 605
2016
Q2 		$1.67M Sell
104,339
-2,785
-3% -$45.1K 0.02% 596
2016
Q1 		$1.77M Buy
+107,124
New +$1.87M 0.02% 564

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

United Capital Financial Advisors's HZNP Position: Q1 2023 in Review

United Capital Financial Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 6,169 shares — an estimated $702K sold.

United Capital Financial Advisors first reported a position in HZNP in Q1 2016 and held it in 17 quarters. The position peaked at $2M in Q1 2017. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

  • United Capital Financial Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • United Capital Financial Advisors sold 6,169 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $702K.
  • United Capital Financial Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016 and held it in 17 quarters.
  • United Capital Financial Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2M in Q1 2017.
  • 553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on United Capital Financial Advisors's 13F filing for Q1 2023, filed 15 May 2023.